Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

MKC8866

SKU: orb1218915

Description

MKC8866 is a selective IRE1 RNase inhibitor (IC50: 0.29 μM in human vitro). MKC8866 inhibits IRE1 RNase in breast cancer cells leading to the decreased production of pro-tumorigenic factors and it can inhibit prostate cancer (PCa) tumor growth.

Images & Validation

Key Properties

CAS Number1338934-59-0
MW361.35
Purity>98% (HPLC)
FormulaC18H19NO7
SMILESO=CC1=C(O)C(OC)=CC2=C1OC(C(CC(N3CCOCC3)=O)=C2C)=O
TargetIRE1 RNase
SolubilityDMSO:16.67 mg/mL (46.13 mM; Need ultrasonic)

Bioactivity

In Vivo
MKC8866 (oral; 300 mg/kg; for 28 days) reduces tumor regrowth post-NSC 125973 withdrawal. Animal model: Female athymic nude mice with MDA-MB-231 tumor. Dosage: 300 mg/kg. Administration: Oral; for 28 days. Result: Reduced tumor regrowth post-NSC 125973 withdrawal.
In Vitro
MKC8866 (20 μM; 6 days) decreases proliferation of all breast cancer cell lines. MKC8866 (20 μM; 48 hours) reduces the number of cells entering S phase. MKC8866 (0.2-10 μM; 3 days) suppresses the viability of all four cell lines in a dose-dependent manner under normal conditions, with the most robust effect in LNCaP cells. MKC8866 (20 μM; 72 hours) is sufficient to completely block NSC 125973-induced expression of XBP1s. Cell Proliferation Assay. Cell line: MCF7, SKBR3, MDA-MB-231 and MCF10A cells. Concentration: 20 μM. Incubation time: For 6 days. Result: Decreased proliferation of all breast cancer cell lines. Cell Cycle Analysis Cell line: MDA-MB-231, MCF7 and SKBR3 cells. Concentration: 20 μM. Incubation time: 48 hours. Result: Reduced the number of cells entering S phase. Cell Cycle Analysis Cell line: LNCaP, VCaP, 22Rv1 and C4-2B cells. Concentration: 0.2, 0.5, 1, 5, 10 μM Incubation time: 3 days. Result: Suppressed the viability of all four cell lines in a dose-dependent manner. Cell Cycle Analysis Cell line: MDA-MB-231 cells. Concentration: 20 μM. Incubation time: 72 hours. Result: Completely blocked NSC 125973-induced expression of XBP1s.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • MKC8866 [orb1308186]

    99.85% (May vary between batches)

    1338934-59-0

    361.35

    C18H19NO7

    1 mg, 50 mg, 100 mg, 5 mg, 10 mg, 25 mg, 1 ml x 10 mM (in DMSO), 200 mg, 2 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

5 mg
$ 320.00
10 mg
$ 510.00
25 mg
$ 840.00
50 mg
$ 1,210.00
100 mg
$ 1,680.00
500 mg
$ 3,340.00